Correlation Between Alvotech and Genmab AS

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Alvotech and Genmab AS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alvotech and Genmab AS into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alvotech and Genmab AS, you can compare the effects of market volatilities on Alvotech and Genmab AS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alvotech with a short position of Genmab AS. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alvotech and Genmab AS.

Diversification Opportunities for Alvotech and Genmab AS

-0.66
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Alvotech and Genmab is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Alvotech and Genmab AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genmab AS and Alvotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alvotech are associated (or correlated) with Genmab AS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genmab AS has no effect on the direction of Alvotech i.e., Alvotech and Genmab AS go up and down completely randomly.

Pair Corralation between Alvotech and Genmab AS

Given the investment horizon of 90 days Alvotech is expected to generate 1.55 times more return on investment than Genmab AS. However, Alvotech is 1.55 times more volatile than Genmab AS. It trades about 0.01 of its potential returns per unit of risk. Genmab AS is currently generating about -0.06 per unit of risk. If you would invest  1,278  in Alvotech on August 27, 2024 and sell it today you would lose (79.00) from holding Alvotech or give up 6.18% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Alvotech  vs.  Genmab AS

 Performance 
       Timeline  
Alvotech 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Alvotech are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Alvotech is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.
Genmab AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Genmab AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Alvotech and Genmab AS Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Alvotech and Genmab AS

The main advantage of trading using opposite Alvotech and Genmab AS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alvotech position performs unexpectedly, Genmab AS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genmab AS will offset losses from the drop in Genmab AS's long position.
The idea behind Alvotech and Genmab AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges